Abstract: The present disclosure relates to a valve for dispensing flowable product from a container under pressure, the valve comprising a stem, a seal coupled to the stem, and a mounting cup configured to mount the valve to the container, wherein each of the stem, seal, and mounting cup comprises a recyclable plastic, and wherein the valve is free from a gasket configured to surround an opening of the container to form a seal between the valve and the container. Also provided herein is a container for dispensing a flowable product under pressure comprising the valve as described above.

Abstract: A device includes memory and a processor. The device receives biometric information. The device receives location information. The device analyzes the received biometric information with stored biometric information. The device analyzes the received location information with stored location information. The device determines whether the received biometric information matches the stored biometric information. The device determines whether the received location information matches the stored location information. The device sends an electronic communication that indicates whether the received biometric information matches the stored biometric information and whether the received local information matches the stored location information.

Abstract: Some embodiments of the present disclosure relate to an additively manufactured transport structure. The transport structure includes cavities into which components that use an external interface are inserted. A plurality of components are assembled and integrated into the vehicle. In an embodiment, the components and frame are modular, enabling reparability and replacement of single parts in the event of isolated failures.

Abstract: An assembly for a turbine engine comprising a plurality of circumferentially arranged segments having first and second confronting end faces. The first and second confronting end faces include a multi-channel spline seal assembly. The multi-channel spline seal assembly includes at least a first and second channel wherein confronting first or second channels can receive at least one spline seal.

Abstract: The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular disease associated with chronic kidney disease.

Abstract: A leading edge high-lift device, that may be deployable from a wing of an aircraft, may include a leading edge and a trailing edge. A lower surface and an upper surface may both extend between the leading edge and the trailing edge. A trailing edge region may be defined by the trailing edge and an adjacent region thereto. A shaping device may be disposed at the trailing edge region and may be movable between a non-activated position and an activated position.

Abstract: Medical device delivery systems and methods for making and using medical device delivery systems are disclosed. An example delivery system for an implantable medical device includes an implantable heart valve including an inner shaft having a proximal end region, a distal end region and a first engagement member disposed along a portion of the distal end region and a tip assembly configured to attach to the inner shaft. The tip assembly includes a nosecone having a distal end region and a proximal end region, a second engagement member disposed within at least a portion of the nosecone, the second engagement member including a first locking member, the first locking member configured to deflect from a first position to a second engaged position. Further, attaching the tip assembly to the inner shaft includes deflecting the first locking member such that the locking member is coupled to the first engagement member.

Abstract: Medical devices and methods for making and using medical devices are disclosed. An example system includes an inner shaft having proximal and distal end regions and a first coupling member disposed along the distal end region, wherein the first coupling member includes a first projection and a first recess. The system also includes a support shaft having proximal and distal end regions and a second coupling member disposed along the proximal end region, wherein the second coupling member includes a second projection and a second recess. The system also includes a locking collar coupled to the inner shaft. Additionally, coupling the inner shaft to the support shaft includes placing at least a portion of the first projection into the second recess, placing at least a portion of the second projection into the first recess and positioning the locking collar along a portion of both the first and second coupling members.

Abstract: Some embodiments of the present disclosure relate to an apparatus including an additively manufactured node. The apparatus includes an additively manufactured interconnect co-printed with the node. The interconnect is configured to connect the node to a component.

Abstract: An apparatus is disclosed for N-plexer filtering for coupled antennas. In example implementations, an apparatus includes a first antenna, a second antenna, a first receiver unit tuned to a first frequency band, and a second receiver unit tuned to a second frequency band. The apparatus also includes multiple antenna feed lines. A first antenna feed line is coupled between the first antenna and the first receiver unit. A second antenna feed line is coupled between the second antenna and the second receiver unit. The second antenna feed line comprises an N-plexer that includes multiple paths. A first path is coupled to the second antenna. A second path is coupled to the second receiver unit and includes a resonator configured to cause the first frequency band to be reflected.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.

Abstract: A surgical device is disclosed. The surgical device includes: a jaw assembly including a first jaw and a second jaw moveable relative to the first jaw; and an articulating assembly removably coupled to the proximal end of the jaw assembly, the articulating including a distal joint member, a proximal joint member, and a pivot pin fixedly coupled to the distal joint member and rotatably coupled to the proximal joint member, wherein the jaw assembly and the distal joint member define a first longitudinal axis extending between a proximal end of the jaw assembly and a distal end of the distal joint member, and the proximal joint member defines a second longitudinal axis.

Abstract: Medical devices and methods for making and using medical devices are disclosed. An example system for delivering an implantable medical device includes an outer shaft having a proximal end, a distal portion and a lumen extending therein. The system includes an inner catheter, wherein the inner catheter extends within at least a portion of the lumen of the outer shaft. The system also includes an actuation shaft extending within a portion of the lumen of the inner shaft, wherein a distal end of the actuation shaft is coupled to a coupling member. The system also includes a plurality of translation members coupled to the implantable medical device and the coupling member. The system also includes a grouping coil wound around at least a portion of each of the plurality of translation members.

Abstract: There is provided a solid pharmaceutical composition for delivering by oral administration a pharmaceutically active binding polypeptide to a region of the intestinal tract comprising a compressed core, wherein the compressed core comprises a pharmaceutically active binding polypeptide and wherein the compressed core is coated with a pH sensitive enteric coating.

Abstract: Optically transparent fiber glass cover substrates for electronic displays. The cover substrates include an optically transparent fiberglass composite layer including a fiberglass layer embedded in a matrix material and an optically transparent hard-coat layer bonded to a top surface of the optically transparent fiberglass composite layer. A bottom surface of the optically transparent fiberglass composite layer may define a bottommost exterior surface of a cover substrate. The bottommost exterior surface of a cover substrate may be disposed over a display surface of an electronic display to protect the display surface from damage.

Abstract: The present disclosure relates to a device to be used with materials testing of fabrics, wherein the materials testing apparatus includes grips with opposing jaw faces. A wedge is provided which is mounted on a bracket which is attached to the grip. The wedge is used to increase surface area of the material against the jaw faces of the grips, which increases the ability of the grips to hold onto the sample/specimen/material during test. The wedge can slide in the bracket or the wedge mount can slide in the bracket to allow it to self-center itself in the grip body.

Abstract: The present disclosure is directed to pharmaceutical packages that include a coating that comprises polysilazane, and methods for the production of such. In one or more embodiments of the present disclosure, a pharmaceutical package may include a glass container comprising a first surface and a second surface opposite the first surface. The first surface may be an outer surface of the glass container. The pharmaceutical package may further include a coating positioned over at least a portion of the first surface of the glass container. The coating may include polysilazane.

Abstract: Methods, devices and systems are disclosed for improved depth perception in stereoscopic night vision devices. Among these are embodiments for aligning information overlays in the stereo view with associated objects, and for generating stereo information from single lenses or intensifiers. In some illustrative embodiments, a camera and position sensor are provided for at least two viewers, e.g., a pilot and a copilot, such that when a scene overlaps between viewers, the system produces a stereoptic scene, in which the users can more accurately determine a difference in depth between two or more distant objects. An illustrative binocular night vision system uses a high-resolution depth map to present binocular images to a user. In some embodiments, supplementary content can be overlaid, with an appropriate binocular disparity that is based on the depth map.